NCT03486028

Brief Summary

California counties are in the process of implementing a Centers for Medicare and Medicaid Services Medicaid 1115 Substance Use Disorder (SUD) demonstration. The demonstration requires that patients be assigned to addiction treatment settings and levels of care systematically, using comprehensive biopsychosocial assessments and guided by the American Society of Addiction Medicine (ASAM) patient placement criteria. RTI International, a nonprofit research institute, and University of California Los Angeles (UCLA) Integrated Substance Abuse Programs have been awarded a contract from the Patient Centered Outcomes Research Institute (PCORI) to study the effects of the ASAM implementation in California. The California 1115 SUD demonstration provides a unique opportunity to learn about the benefits and challenges resulting from system-wide implementation of ASAM criteria. The study will involve surveying patients in counties that are using the ASAM criteria and in counties that have not yet adopted the ASAM criteria. Medicaid patients receiving addiction treatment will be offered the opportunity participate in the study and to be surveyed about their experiences in treatment. The study will also analyze data from the California Outcomes Management System (CalOMS) and conduct interviews with providers, patients, and policymakers in the state. The results of the study will help inform California's efforts to continually improve its addiction treatment systems to better meet the needs of it communities. This study will also produce important and useful information to patients seeking treatment for addiction, and their providers, SUD system administrators, and payers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
991

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 3, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

July 31, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2019

Completed
Last Updated

November 26, 2019

Status Verified

November 1, 2019

Enrollment Period

1.1 years

First QC Date

March 26, 2018

Last Update Submit

November 25, 2019

Conditions

Keywords

Patient-Centered Outcomes Research Institute (PCORI)American Society of Addiction Medicine (ASAM)substance useaddictiontreatmentRTI InternationalUCLA

Outcome Measures

Primary Outcomes (2)

  • Treatment Retention

    Retention in treatment for at least 14 days is a validated outcome measure and has been shown to be predictive of reduced substance use, 2-year mortality, criminal justice involvement, and detox episodes. Retention in treatment can be measured with the CalOMS data.

    Up to one year

  • Substance Use Reduction

    Abstinence and reduction in substance use is necessary for patients to achieve recovery and improved psychosocial functioning. We will measure this patient reported outcome (PRO) using the patient survey and CalOMS data. Through the patient survey, we will ask about use of any alcohol in the past 30 days, use of any drugs in the last 30 days, and the number of heavy drinking days in the last 30 days. These data will be collected from patients 3 months from treatment-episode initiation. Substance use is also collected from all patients treated in public SUD clinics in California at the beginning and end of each treatment episode and is recorded into the CalOMS data.

    Up to one year

Secondary Outcomes (2)

  • Treatment setting used at treatment initiation

    Up to one year

  • Treatment option communication

    Up to one year

Study Arms (3)

ASAM Counties/non-computerized

Pre- and 1115-waived counties that are implementing the ASAM. Intervention is adherence to ASAM protocols.

Other: Adherence to ASAM protocols

ASAM Counties/computerized

Counties using a computerized system to assist in intervention determination according to ASAM protocols. Intervention is adherence to ASAM protocols.

Other: Adherence to ASAM protocols

Non-ASAM Counties

Pre- and non-waived "control" counties that are not implementing the ASAM. Intervention is non-adherence to ASAM protocols.

Other: Non-adherence to ASAM protocols

Interventions

ASAM Counties. These counties are requiring their providers to use ASAM criteria to assess patients and to determine level of care. These counties also use ASAM to determine the ongoing need for high-intensity services, such as residential, and approve those services for Medicaid payment.

ASAM Counties/computerizedASAM Counties/non-computerized

These counties are not implementing the ASAM criteria to assess patients and determine the level of care.

Non-ASAM Counties

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals age 19 or older receiving treatment for addiction in specialty addiction treatment programs licensed in California who are Medicaid beneficiaries.

You may qualify if:

  • Individuals age 19 or older
  • Receiving treatment for addiction in specialty addiction treatment programs licensed in California who are Medicaid beneficiaries.

You may not qualify if:

  • Less than 19 years old
  • Not receiving treatment for addiction in specialty addiction treatment programs licensed in California
  • Not Medicaid beneficiaries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RTI International

Research Triangle Park, North Carolina, 27709, United States

Location

MeSH Terms

Conditions

Substance-Related DisordersBehavior, Addictive

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersCompulsive BehaviorImpulsive BehaviorBehavior

Study Officials

  • Tami Mark, PhD, MBA

    RTI International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2018

First Posted

April 3, 2018

Study Start

July 31, 2018

Primary Completion

September 1, 2019

Study Completion

October 27, 2019

Last Updated

November 26, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations